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Glutamate signalling is increasingly implicated across a range of psychiatric, neurological
and pain disorders. Reliable methodologies are needed to probe the glutamate
system and understand glutamate dynamics in vivo. Functional magnetic resonance
spectroscopy (1H-fMRS) is a technique that allows measurement of glutamatergic
metabolites over time in response to task conditions including painful stimuli. In this study,
18 healthy volunteers underwent 1H-fMRS during a pressure-pain paradigm (8 blocks
of REST and 8 blocks of PAIN) across two separate sessions. During each session,
estimates of glutamate + glutamine (Glx), scaled to total creatine (tCr = creatine +
phosphocreatine) were determined for averaged REST and PAIN conditions within two
separate regions of interest: the anterior cingulate cortex (ACC) and dorsal ACC (dACC).
A two-way repeated measures analysis of variance determined a significant main effect
of CONDITION (p = 0.025), with higher Glx/tCr during PAIN compared to REST across
combined sessions, in the dACC ROI only. However, increases in dACC Glx/tCr during
PAIN compared to REST showed limited reliability and reproducibility across sessions.
Future test-retest 1H-fMRS studies should examine modified or alternative paradigms to
determine more reliable methodologies to challenge the glutamate system that may then
be applied in patient groups and experimental medicine studies.
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INTRODUCTION
Glutamate, amajor excitatory neurotransmitter, is fundamentally involved in normal and abnormal
brain function (1). Glutamate plays a central role in a number of pathologies including psychiatric
(2), neurological (3), neurodevelopmental (4) and pain disorders (5). Proton magnetic resonance
spectroscopy (1H-MRS) is a non-invasive in vivo technique that allows the measurement of
regional concentrations of brain metabolites, including glutamate, and has proved integral in
furthering our understanding of the role of glutamate in health and disease (6). However, a
significant limitation of standard 1H-MRS is that measures are determined over a single resting
(static) time period, preventing dynamic glutamate responses from being studied.
Functional 1H-MRS (1H-fMRS) is a technique where sequential 1H-MRS scans are acquired
to measure dynamic changes in metabolite concentrations. There has been particular interest in
using 1H-fMRS methods to investigate changes in glutamate induced by tasks and other stimuli
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(7). Compared with standard static 1H-MRS glutamate
measurements, the signal change detected with 1H-fMRS may
relate more closely to glutamate involved in neurotransmission
(7, 8). 1H-fMRS studies have demonstrated significant dynamic
increases in glutamate measures in the occipital cortex during
visual stimuli presentation (9–13) and in the motor cortex during
motor stimuli (14, 15). 1H-fMRS studies have also demonstrated
significant increases in glutamate measures in healthy controls
in the anterior cingulate cortex (ACC) during cognitive tasks
including the Stroop task (16–18) and increases in Glx/tCr
(glutamate + glutamine referenced to total creatine) in the N-
back task (19). However, increases in ACC glutamate measures
were not seen in patients with major depressive disorder or
schizophrenia during the Stroop task (18), neither were increases
in Glx/tCr detected in patients with schizophrenia or bipolar
disorder II during the N-back task (19). These previous data
emphasise the potential of 1H-fMRS to investigate abnormalities
in glutamate dynamics associated with psychiatric disorders.
Potential challenges associated with the use of cognitive
paradigms include the influence of task-learning effects, and
individual or group differences (healthy vs. patient) inmotivation
or ability to complete the task. Additionally, the magnitude of
the glutamate response detected in 1H-fMRS cognitive studies is
relatively small (8). In contrast, the use of painful stimuli may
avoid some of these potential confounds and appear to elicit the
largest 1H-fMRS glutamate responses (7). 1H-fMRS pain studies
have demonstrated increases in glutamate and Glx in the ACC
during a cold-pressor task (20); an increase in Glx/tCr in the
dorsal ACC (dACC) (21), increased concentrations of glutamate
and Glx in the dACC (22), an increase in glutamate in the insula
(23) following painful heat stimuli; and an increase in Glx/tCr in
the insula during dental pain (21). There is some inconsistency
in 1H-fMRS pain findings with one study reporting reductions
in glutamate levels in the dACC following heat pain exposure
(24) while another found no change in Glx/tCr in the insula
during dental pain (25). Furthermore, none of these 1H-fMRS
pain studies have employed a test-retest design and the reliability
of any elicited 1H-fMRS responses has not been described.
Findings from a recent functional magnetic resonance
imaging (fMRI) study, that demonstrated robust, reliable
estimates of blood oxygen-level-dependent (BOLD) signal and
self-reported pain in response to noxious pressure across two
separate sessions (26), suggests that pressure as a stimulation
modality is an alternative viable method in the study of pain.
Similar to thermal heat paradigms (21, 23), experimental pressure
pain paradigms allow the ability to control stimulus intensity
and delivery accounting for individual pain thresholds and can
be practically delivered within an MR environment (26). In this
study, we aimed to determine if pressure pain stimulation could
be applied to generate reliable changes in a glutamate measure
(Glx/tCr) as measured by 1H-fMRS. 1H-fMRS was employed
to examine pressure pain-induced dynamic Glx/tCr responses
across two separate sessions in healthy volunteers in the ACC,
a region known to be activated during pain perception (27, 28)
and the dACC, a region in which previous 1H-fMRS studies have
reported increases in glutamate, Glx and Glx/tCr during painful
stimuli (21, 22). We hypothesised that Glx/tCr would be elevated
in these regions during a pressure pain condition relative to a
resting passive visual fixation condition.We further hypothesised
that changes in Glx/tCr between the rest and pain conditions
would be related to subjective pain rating scores.
MATERIALS AND METHODS
Participants
Eighteen healthy subjects (mean age 25 ± 4.74, male/female:
9/9, right/left-handed: 17/1) were recruited via local and
online advertisements. Volunteers with a history of psychiatric,
neurological, chronic pain condition, or history of hand/thumb
trauma were excluded. Volunteers with major medical illness
requiring medication, magnetic resonance imaging (MRI)
contraindications or history of substance or alcohol abuse were
also excluded from the study. Previous work has indicated
variability in the pain responses of females depending on the
phase of the menstrual cycle (29). Female volunteers completed
test- retest sessions within the equivalent phase of consecutive
months and those with irregular menstrual cycles were excluded.
To minimise the influence of diurnal variations on pain (30,
31), participants were all tested at the same time in the day.
Before each visit, participants were required to abstain from
paracetamol or non-steroidal anti-inflammatory drugs for 12 h.
Prior to any experiments all volunteers were informed about the
study procedures, potential risks and provided written informed
consent. The study was approved by the local Ethics Committee
(Reference HR-18/19-8825).
Study Sessions
All participants attended four separate sessions. In the first
session participants underwent a thresholding procedure for
pressure pain stimulation, which took place in a mock scanner
environment. This was followed by the first imaging session that
took place within 1 week of the thresholding session, where the
pressure pain paradigm was administered in an MRI scanner.
The third and fourth sessions were repeats of the first and
second sessions respectively (i.e., second thresholding and second
imaging session), and occurred after an interval of 4 weeks.
The second thresholding session was performed to account for
potential changes in individuals pain threshold over time. The
mean interval between the two imaging sessions was 28.44 days,
SD = 3.50. The mean interval between the thresholding and
imaging sessions was 3.92 days, SD= 2.56.
Pressure Pain Thresholding Sessions
Pressure stimuli were applied to the thumbnail of the non-
dominant hand using a custom-made, automated, pneumatic,
computer-controlled stimulator with a plastic piston that applies
pressure via a 1.13 cm2 hard rubber probe (26, 32). The thumb
was inserted into a cylindrical opening and positioned such that
the probe applied pressure directly to the nail bed. To maintain
consistency, the same pressure device was used for both the
thresholding sessions and the pressure pain paradigm in the
imaging sessions.
The pressure pain thresholding procedure (26) involved one
ascending series and one randomised series of pressure stimuli.
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During the ascending series of pressure stimuli, participants first
received stimulation at 55 kilopascals (kPa) for 2 s duration.
Subsequent pressure stimulations increased in steps of 4 kPa,
delivered at 4 s intervals, again each lasting 2 s duration. First,
participants were required to inform the investigator when they
had reached their minimum pain threshold (pain score > 0
on a pain scale where 0 = “no pain” and 100 = “worst pain
imaginable”). Second, participants were asked to inform the
investigator when they reached their moderate pain threshold
[pain score = 70 (70%)]. These values from the ascending series
were then used to compute the magnitude of five different
pressure intensities within the range of each subject’s minimum
and moderate pain thresholds. For example, if a subject’s
minimum pain threshold was represented by a pressure of 200
kPA and moderate pain threshold [pain score = 70 (70%)]
was reached at a pressure of 600 kPA then the randomised
series would consist of pressures of 200, 300, 400, 500, and
600 kPa. Subsequently, during the randomised series, each of
these five pressure stimulations were delivered three times (15
stimuli in total) for a duration of 2 s in a pseudo-randomised
order at 24 s intervals. During each interval participants were
required to rate the intensity of their pain on a computerised
pain visual analogue scale (VAS) that was presented on screen
for 7 s, using their contralateral hand. Finally, a linear function
was used to determine each individual’s representation of a
pain score of 60 (60%), built on the 15 ratings from the
randomised series.
Imaging Sessions
Participants first underwent localiser and structural scans
followed by the pressure pain paradigm (Figure 1), utilising
the same pressure probe device as used in the thresholding
sessions. The paradigm was a block design consisting of
sixteen alternating blocks of rest (no stimulation, passive visual
fixation) and pressure pain stimuli delivered at each individual’s
pain score of 60% determined from the previous thresholding
session. The rationale for delivering pressure set for a pain
score of 60%, rather than 70% (moderate pain threshold),
was to account for the repeated pressure stimuli applied in
the paradigm and to make the experiment more tolerable for
participants. Each block was 48 s in duration. In the pressure
pain stimulus block, each pressure stimulus had a duration of
2 s, separated by a 6 s interval and for each stimulus block
there were six pressure stimuli in total. At the end of each
pressure pain stimuli block, participants were presented with
a computerised VAS of the pain scale, as in the thresholding
session, but displayed for 8 s. Apart from when the VAS was
on screen, a fixation cross was displayed for the rest of the
paradigm. The total duration of one run of the pressure pain
paradigm was 832 s. Participants completed one run per voxel
(both on the non-dominant hand) with a 5-min break to
rest their hand, during each of the imaging sessions. The
procedure for the second imaging session was identical to
the first apart from the pressure pain stimuli delivered that
depended on the values determined from each individual’s
second thresholding session.
1H-fMRS Data Acquisition
The data were acquired using a GE Discovery MR750 3.0T
scanner equipped with a 32-channel receive-only head coil at
the Centre for Neuroimaging Sciences, King’s College London,
UK. A high-resolution structural 3D IR-SPGR sequence (TR =
7.31ms, TE = 3.02ms, TI =400ms, FOV = 270mm, flip-angle
(a) = 11◦, matrix size = 256 × 256, slice thickness = 1.2mm,
196 slices) in the sagittal plane was first acquired for localisation
of the spectroscopy voxels. 1H-fMRS spectra were acquired in
two separate brain regions of interest (ROI) during the pressure
pain paradigm (Figure 2). ROI-1 was an anterior cingulate cortex
(ACC) region where the voxel measured 20 × 20 × 20mm with
the centre of the voxel placed 16mm above the genu of the corpus
callosum perpendicular to the anterior commissure- posterior
commissure line (Figure 3A). This non-rotated ACC voxel aligns
with that used in our previous 1H-MRS studies in patient groups
(33, 34). ROI-2 was a dorsal ACC (dACC) region where the voxel
measured 40× 20× 15mm and was positioned at an angle to sit
immediately above the corpus callosum, with the anterior edge
of the voxel aligned with the anterior edge of the genu of the
corpus callosum (Figure 3B). The order of 1H-fMRS acquisition
was fixed with data collected from ROI-1 (ACC) first and ROI-2
(dACC) second for all participants.
The 1H-fMRS spectra were acquired individually throughout
the pressure pain paradigm using Point RESolved Spectroscopy
(PRESS), with CHEmical Selective Suppression for water
suppression and outer volume suppression (OVS) with Very
Selective Suppression (VSS) pulses (TR = 2,000ms, TE = 105ms,
phase cycle length= 2, 420 acquisitions, 16 water unsuppressed
acquisitions). Before each 1H-fMRS scan, shimming was
optimised with an auto-prescan performed twice. A modified
version of GE’s PROBE (proton brain examination) sequence was
used to commence the pressure pain paradigm and send a trigger
pulse at the start of every TR.
1H-fMRS Analysis
Analysis of 1H-fMRS data was performed using the TARQUIN
software package, version 4.3.10 (35). The TARQUIN algorithm
performed a fully automated fit to the 1H-fMRS data using a
predefined basis set comprising of the following components:
alanine; aspartate; creatine (Cr); gamma-aminobutyric
acid; glucose; glutamine; glutathione; glutamate (Glu);
glycerophosphorylcholine; myo-inositol; lactate; lipid peaks
at 0.9, 1.3a, 1.3b, and 2.0 ppm; macromolecules at 0.9,
1.2, 1.4, and 2.0 ppm; N-acetyl-aspartate (NAA); N-acetyl-
aspartateglutamate; phosphorylcholine; phosphocreatine (PCr);
scyllo-inositol; and taurine.
1H-fMRS spectra acquired during the “REST” and “PAIN”
conditions (8 blocks of each) from each ROI were averaged
within subjects and estimates of Glx (Glu + glutamine) were
determined. Only Glx values were reported as with the TE
used in this study glutamate and glutamine may not be reliably
differentiated. Averaged 1H-fMRS spectra had to meet the
following quality control measures to be included in subsequent
analysis: (1) Cramer-Rao minimum variance bounds (CRMVB)
estimate of the standard deviation of Glx < 20%; (2) signal-to-
noise ratio (SNR) > 5; (3) full-width half- maximum (FWHM)
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FIGURE 1 | Pressure pain paradigm. Each block of REST and PAIN was 48 s in duration. In the PAIN blocks, each pressure stimulus had a duration of 2 s, separated
by a 6 s interval. A VAS pain scale was displayed for 8 s at the end of each PAIN block.
FIGURE 2 | Temporal sequence of 1H-fMRS measurements and regions. 1H-fMRS measurements were first acquired from ROI 1 (ACC) during the pressure pain
paradigm. There was then a 5min break and subsequently 1H-fMRS measurements were acquired from ROI 2 (dACC) during a second run of the same pressure pain
paradigm. The 1H-fMRS sequence was identical for each ROI (TR = 2,000ms, TE = 105ms, phase cycle length = 2). Twenty four suppressed acquisitions were
acquired during each of the eight REST and PAIN blocks with 16 water unsuppressed acquisitions acquired at the end of the 1H-fMRS sequence for each run.
< 0.1 ppm and (4) fit quality (Q) < 2.5. No spectra had to be
discarded following the quality control process. Total creatine
(tCr = Cr + PCr) was used to provide a reference for Glx
values in each sub spectrum to alleviate possible confounds of
scanner drift that would not be adequately corrected if a single
water reference that was acquired at the end of the scan was
used instead.
To assess consistency of voxel tissue composition, IR-SPGR
images were segmented using SPM12 (http://www.fil.ion.ucl.ac.
uk/spm/software/spm12/) into grey matter (GM), white matter
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FIGURE 3 | Example voxel positioning and associated 1H-fMRS spectra (for a single subject) for ROI 1- ACC (A) and ROI 2- dACC (B). The screen shots of the
orthogonal views are taken through the center of each plane of each of the voxels. Example TARQUIN output is shown for REST and PAIN conditions with output of
the fit (red) overlaid on the acquired spectrum (black). The estimated baseline is displayed under each spectrum in black.
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(WM) and cerebrospinal fluid (CSF) andmean tissue proportions
and standard deviations were determined across subjects and
scanning sessions.
Statistics
Normality of data was examined using Shapiro–Wilk tests. To
evaluate a priori hypotheses, two-way repeated measures
analyses of variance (ANOVAs) were used to examine
differences in Glx/tCr, with CONDITION (REST and PAIN)
and SESSION (Session A and Session B) as within-subject
factors, including CONDITION∗SESSION interaction terms,
for each ROI individually. As future research applications
may wish to evaluate Glx/tCr responses during a single
scanning session (for example in case-control designs), and
to facilitate qualitative comparison with previous research
using similar sample sizes that applied only a single session
(21, 22), we additionally investigated whether effects of
CONDITION reached significance in session A alone, using
paired samples t-test.
To assess the test-retest reliability across scanning
sessions for the change in Glx/tCr in the PAIN compared
to REST condition, the intra-class correlation coefficient
(ICC), was computed using a two-way mixed effects model,
single measurement for absolute agreement alongside the
within-subject percentage coefficient of variation (%CV).
Test-retest variability (VAR) was also computed to assess
reproducibility. Reliability and reproducibility tests was only
evaluated where significant main effects of CONDITION
were detected.
Exploratory analyses examined for potential adaptation
effects for Glx/tCr across individual blocks of the pressure pain
paradigm using three-way repeated measures ANOVAs with
BLOCK, CONDITION and SESSION as within-subject
categorical factors (including BLOCK∗CONDITION,
BLOCK∗SESSION, CONDITION∗SESSION and
BLOCK∗CONDITION∗SESSION interaction terms). These
analyses were performed separately for each ROI and all Glx
values for individual blocks, including those with CRMVB
>20%, were included.
Finally, Pearson’s product moment correlation coefficients
were used to examine any relationships between 1Glx/tCr
between REST and PAIN conditions and VAS pain scores
(averaged within-subject and compared across subjects) for each
scanning session. For all analyses, a significance threshold of p
< 0.05 was specified. Analyses were carried out using R version
3.6.3 and IBM SPSS Statistics version 27.
RESULTS
Pain VAS Scores
The mean stimulus pressures delivered (determined from
thresholding sessions) and mean pain VAS scores from
the 1H-fMRS pressure pain paradigm for each ROI are
shown in Table 1. The mean stimulus pressure delivered
and mean pain VAS scores for each ROI remained stable
with no statistically significant differences across sessions
(Table 1). Mean pain VAS scores were higher for the second
run, dACC (ROI-2), than the first run, ACC (ROI-1) for
both sessions. Mean pain VAS scores across individual
PAIN blocks and across sessions for each ROI are shown
in Supplementary Figure 1.
Metabolite Ratio Differences (Pressure
Pain Paradigm)
Two-way repeated measures ANOVA demonstrated a significant
main effect of CONDITION for Glx/tCr in the dACC (ROI-
2) [F(1,17) = 6.075, p = 0.025], with higher Glx/tCr during
PAIN compared to REST. There was no significant main effect
of SESSION [F(1,17) = 0.672, p = 0.424] and no significant
CONDITION ∗ SESSION interaction [F(1,17) = 0.028, p =
0.870] for dACC Glx/tCr (Table 2). dACC Glx/tCr during REST
and PAIN is presented in Table 3 and Figure 4. The increase
in dACC Glx/tCr during PAIN compared to REST did not
reach statistical significance for session A alone [t(17) = 2.012,
p= 0.060].
For 1Glx/tCr in the dACC ROI between the averaged
blocks of REST and PAIN there was poor test-retest reliability
(ICC = 0.272, %CV = 10.5%) and limited reproducibility
(VAR = 10.3). There was no significant relationship between
1Glx/tCr in the first and second sessions (r = 0.264,
p= 0.289).
For Glx/tCr in the ACC (ROI-1), there was no significant
CONDITION ∗ SESSION interaction [F(1,17) = 0.202, p= 0.659]
and no significant main effects of CONDITION [F(1,17) = 2.620,
p= 0.124] or SESSION [F(1,17) = 2.703, p= 0.119] (Table 2).
Exploratory analyses with a three-way repeated measures
ANOVA, examining Glx/tCr across individual blocks,
demonstrated a significant main effect of CONDITION for
Glx/tCr in the dACC [F(1,17) = 10.407, p = 0.005] with
no significant interactions (i.e., BLOCK∗CONDITION,
BLOCK ∗ SESSION, CONDITION∗ SESSION or
BLOCK∗CONDITION∗SESSION) and no significant main
effects of BLOCK or SESSION (Supplementary Table 1).
For Glx/tCr in the ACC (ROI-1) there were no significant
interactions and no significant main effects of BLOCK,
CONDITION or SESSION for the repeated measures ANOVA
(Supplementary Table 1).
Uncorrected tCr signal values were found to be stable
for averaged REST and PAIN conditions and across
sessions with no significant CONDITION ∗ SESSION
interactions and no significant main effects of CONDITION
or SESSION for either ROI (Table 2). Furthermore,
tCr signal values remained stable across individual
blocks of REST and PAIN (Supplementary Figure 2).
Three-way repeated measures ANOVAs revealed no
significant interactions and no main effects of BLOCK,
CONDITION or SESSION on tCr values in either ROI
(Supplementary Table 1).
Tissue Segmentation and SNR
For the ACC ROI, the mean ± standard deviation tissue
proportions were 65 ± 4% GM, 10 ± 3% WM, 25 ±
6% CSF and 65 ± 4% GM, 10 ± 3% WM, 25 ± 5%
CSF for session A and B respectively. For the dACC ROI,
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TABLE 1 | Mean stimulus pressure values and pain VAS scores.
SESSION A, mean (SD) SESSION B, mean (SD) p
Stimulus pressure delivered (kPa)
(Determined from thresholding session)
676 (115) 665 (95) 0.58
Average Pain VAS ROI-1 (ACC) (All blocks) 53.3 (10.3) 53.8 (8.4) 0.85
Average Pain VAS ROI-2 (dACC) (All blocks) 59.9 (13.6) 61.3 (13.4) 0.76
p, p-value pairwise comparisons (alpha = 0.05, two-tailed).
TABLE 2 | Two-way ANOVA summary table for Glx/tCr and tCr for each ROI.
ROI and metabolite Source df MS F p
ACC (ROI-1) [Glx/tCr] CONDITION 1 0.015 2.620 0.124
Error (CONDITION) 17 0.006
SESSION 1 0.035 2.703 0.119
Error (Session) 17 0.013
CONDITION*SESSION 1 0.002 0.202 0.659
Error (CONDITION * SESSION) 17 0.008
ACC (ROI-1) [tCr] CONDITION 1 0.088 0.403 0.534
Error (CONDITION) 17 0.219
SESSION 1 0.196 0.218 0.647
Error (Session) 17 0.901
CONDITION*SESSION 1 0.050 0.246 0.626
Error (CONDITION * SESSION) 17 0.204
dACC (ROI-2) [Glx/tCr] CONDITION 1 0.040 6.075 0.025
Error (CONDITION) 17 0.007
SESSION 1 0.018 0.672 0.424
Error (Session) 17 0.027
CONDITION*SESSION 1 0.000 0.028 0.870
Error (CONDITION * SESSION) 17 0.004
dACC (ROI-2) [tCr] CONDITION 1 0.395 0.939 0.346
Error (CONDITION) 17 0.420
SESSION 1 0.009 0.004 0.947
Error (Session) 17 1.932
CONDITION*SESSION 1 0.300 1.331 0.265
Error (CONDITION * SESSION) 17 0.226
(df = degrees of freedom; MS = Mean Squares). The bold values indicate a significant effect (p < 0.05).
the mean tissue proportions were 63 ± 4% GM, 21 ±
6% WM, 16 ± 5% CSF and 62 ± 4% GM, 21 ± 6%
WM, 16 ± 5% CSF for sessions A and B, respectively. The
relatively small spread of proportions indicates consistency
of voxel position across subjects. Furthermore, there were
no significant differences in GM, WM and CSF tissue
proportions between sessions indicating consistency of voxel
positioning across scans (Supplementary Table 2). Example
voxel positioning and corresponding 1H-fMRS spectra are shown
in Figures 3A,B.
For total averaged block conditions, mean SNR for the ACC
ROI was 31.4 ± 5.7 for REST and 31.5 ± 5.8 for PAIN. For the
dACC ROI, these values were 34.9± 5.0 and 35.4± 4.6 for REST
and PAIN conditions, respectively. There were no significant
differences in SNR between REST and PAIN conditions in either
ROI (Supplementary Table 3).
Relationship Between Glx/tCr Changes
and Pain VAS Scores
Correlations between 1Glx/tCr values and pain VAS are shown
in Table 4. There were no consistent significant associations
between 1Glx/tCr (PAIN–REST) conditions and pain VAS for
all blocks combined across each scanning session.
DISCUSSION
In this study we utilised 1H-fMRS at 3T in a test-retest design
to examine dynamic changes in Glx/tCr in response to acute
pressure pain stimulation within the ACC and dACC. The pain
paradigm elicited a statistically significant increase in dACC
Glx/tCr overall across both scanning sessions. However, these
changes were associated with limited within-subject reliability.
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TABLE 3 | Mean Glx/tCr for REST and PAIN conditions and 1Glx/tCr across combined and individual sessions in the dACC (ROI-2).
REST
[Glx/tCr]





Sessions combined 1.04 0.13 0.02 1.08 0.17 0.03 0.05 (CI 0.01,
0.09)
+4.52
Session A 1.06 0.14 0.03 1.10 0.18 0.04 0.05 (−0.00,
0.09)
+4.26
Session B 1.02 0.12 0.03 1.07 0.17 0.04 0.05 (−0.02,
0.11)
+4.88
[Glx/tCr], Glx (glutamate + glutamine) scaled to total creatine; SD, Standard Deviation; SE, Standard Error.
FIGURE 4 | Glx/tCr in the dACC (ROI-2) during REST and PAIN conditions for scanning sessions (A,B).
Overall, these results indicate that this paradigm does elicit
increases in dACC Glx/tCr, but the reliability of this effect may
be insufficient for some future applications.
The cingulate cortex is functionally heterogenous (28) and
has been shown to be involved in a range of functions related
to pain including the perception of pain, attention to pain
and emotional processing of pain (27, 36, 37). Several previous
studies have utilised 1H-fMRS to investigate changes in glutamate
measures in ACC/dACC regions during painful stimuli in healthy
volunteers (20–22, 24, 38, 39), however none have reported
the associated test-retest reliability. While some studies have
reported significant increases in Glu (20, 22), Glx (20, 22)
and Glx/tCr (21), others have found no significant changes in
glutamate (38, 39) or reductions in glutamate during noxious
stimulation (24). The significant increase in dACC Glx/tCr
we observed in our pressure pain paradigm across combined
scanning sessions (4.5%) is lower in magnitude than the increase
in Glx/tCr (21.5%) previously reported during heat stimuli in
an event related design (21). The lack of any significant findings
in the ACC ROI in our study could be explained by our choice
of pain stimulus that did not reliably engage this area. When
a similar pressure-pain paradigm was used in a fMRI study,
peak BOLD coordinates during noxious stimulation were not
observed in the ACC, but instead more posterior cingulate cortex
regions (26). Although our dACC voxel was similarly positioned
to that used in the studies by Cleve et al. (21) and Archibald
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ROI-1 (ACC) 1 [Glx/tCr] 0.38 0.12
ROI-2 (dACC) 1 [Glx/tCr] 0.14 0.58
Session B
ROI-1 (ACC) 1 [Glx/tCr] −0.09 0.72
ROI-2 (dACC) 1 [Glx/tCr] 0.15 0.56
et al. (22), the less robust Glx/tCr change in our study may be
explained by the pain stimulus used (pressure rather than heat),
or differences in acquisition parameters, including T1 and T2
weighting, that might have also contributed. While Archibald
et al. (22) acquired interleaved non-water suppressed spectra,
allowing absolute metabolite quantification, in our study the
water unsuppressed acquisitions were non-interleaved, acquired
at the end of the sequence, necessitating the use of tCr scaling
that may have led to a relative underestimate of Glx signal
change. It should be noted that in the study by Cleve et al.
(21), only female participants were included and Archibald et al.
(22) reported nominally larger increases in glutamate and Glx in
response to pain in females. Our study was not powered to detect
metabolite ratio differences between genders, however future 1H-
fMRS research should include gender-based analyses to better
understand potential differences in glutamatergic signalling
between the sexes.
Although there was no significant BLOCK by CONDITION
interaction for dACC Glx/tCr, qualitative inspection of the
data indicated diminishment of Glx/tCr responses on repeated
stimulation (Figure 5), which may be of neurobiological interest
as well as presenting a practical challenge for future 1H-fMRS
studies. This pattern of reducing dACC Glx/tCr across pain
blocks suggests potential adaptation/ habituation effects may be
occurring within the glutamate system on repeated stimulation
(7). This is comparable with findings from Archibald et al.
(22) that demonstrated increased concentrations in glutamate
measures at the onset of pain but continued painful stimulus was
not accompanied by corresponding changes in glutamate or Glx.
While increasing the quantity of painful stimuli has the potential
to increase power, if the stimuli are repetitive (and predictable)
then a repetition suppression effect may be present, accompanied
by reductions in glutamate (40). In agreement with Archibald
et al. (22), we found no relationship between pain ratings and
Glx/tCr concentrations. Together, this supports a hypothesis that
greater increases in dACC glutamate measures may be involved
in the initial detection of novel noxious stimuli but less so in the
tracking of repeated painful stimuli. Indeed, it has been proposed
that an extensive cortical network that is particularly responsive
to nociceptive stimuli (including the cingulate, somatosensory,
insular, frontal and parietal areas), often referred to as the
“pain matrix,” may reflect a salience detection system (41). This
network could reflect a mechanism through which significant
events for the body’s integrity are detected, acting as a defensive
system, alerting to potential damaging or dangerous threats (41).
Therefore, the context within which the painful stimuli appear
is key. With an experimentally evoked painful stimulus such as
ours, participants implicitly know they will not come to any
harm, which contrasts with prolonged and inescapable pain seen
in chronic pain patients or other models.
The precise mechanisms underlying increases in Glx/tCr
in response to painful stimulation and detected by 1H-fMRS
are not yet clear. One potential mechanism could involve
increased metabolic turnover during activation through various
pathways including increased glutamate/glutamine cycling,
increased energy production rate through the tricarboxylic acid
cycle (TCA) (12, 42) and increased flux through the malate-
aspartate shuttle (MAS) (9, 43). Another speculative theory of
“compartmental shifts” proposes that glutamate may be less or
more MRS visible, depending on its location within vesicles or
within synaptic, extracellular and astrocytic pools, respectively
and on MRS acquisition parameters (7, 8, 44). Further studies
using 13C MRS (45) and at higher field strengths to separate
glutamate and glutamine are required to understand these
mechanisms further.
Strengths of our study include the application advantages
of our noxious pressure paradigm including practicality,
ability to control pain level (tailored to individual thresholds)
and reliability of self-reported pain measures as previously
demonstrated (26). Furthermore, to our knowledge, this is the
first 1H-fMRS pain study to report on test-retest reliability
across separate imaging sessions. One limitation to this study
is the low sample size (n = 18). Although this is comparable
to previous studies [n = 18 (22), n = 20 (21), n = 12
(20)], power was limited by the relatively smaller effect sizes
for 1Glx/tCr that were observed in our paradigm, with the
effect of condition not reaching significance during the first
session alone. Larger sample sizes are recommended for future
studies which aim to investigate between-subjects differences in a
single scanning session using this paradigm. Despite advantages
associated with the pressure pain paradigm employed here, there
are also limitations which may explain the less robust glutamate
measure change. Although block-design analyses were employed
with a view to increase statistical power, the pressure stimuli
were not continuous throughout the PAIN block. Although
this design was chosen to make the experiment more tolerable
for participants, glutamate signal may have decreased when
the stimuli were not present. To achieve more robust, reliable
increases in glutamate measures, applying the pressure stimuli
for a longer duration with less repetitions may be preferable.
As mean pain VAS scores were higher for the second run of
the paradigm (dACC) than the first run (ACC), this suggests a
potential effect of sensitisation. Since the experimental order for
the ROIs was fixed, we cannot exclude potential order effects
and the possibility that pain-induced dACC Glx/tCr changes
may have been lesser (or ACC Glx/tCr greater) if the acquisition
order was reversed. The TE of 105ms was chosen based on
a previous glutamate 1H-fMRS study (40), however, this TE is
quite long with significant J-modulation and attenuation due to
T2 relaxation and therefore may not have been most optimal.
Future 1H-fMRSwork should directly compare long and short TE
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FIGURE 5 | Mean Glx/tCr for individual REST and PAIN blocks across scanning sessions: (A) ACC Glx/tCr, (B) dACC Glx/tCr. REST condition is shown in blue solid
line and PAIN condition is shown in red dashed line. Error bars represent the 95% CI.
times to assess reliability of glutamate/glutamine/Glx measures.
Finally, acquired 1H-fMRS signals were not corrected for tissue
type or relaxation differences and instead were referenced to tCr
which reduces the need for tissue content correction. Although
there were no significant differences in tissue proportions
between scan sessions it is possible detected metabolite ratio
changes may have been influenced by small differences in voxel
tissue content.
CONCLUSIONS
As glutamatergic signalling is increasingly implicated across
a range of psychiatric, neurological and pain disorders
there is a need to develop reliable methodologies for
probing the glutamate system and understanding glutamate
dynamics. Such tools may ultimately be used to develop
further understanding of biological illness mechanisms and
support in the development of glutamate-acting drugs.
While our pressure-pain 1H-fMRS paradigm demonstrated
the feasibility of detecting increases in Glx/tCr associated
with pressure-pain in the dACC across combined scanning
sessions, the magnitude was variable within-subjects
and was not sustained across the entire paradigm. We
recommend alternative stimuli, paradigms and acquisition
parameters are tested in future test-retest 1H-fMRS studies to
determine more reliable methodologies for probing glutamate
dynamic responses in patient groups and future experimental
medicine studies.
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